BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23192487)

  • 1. Chronic metformin associated cardioprotection against infarction: not just a glucose lowering phenomenon.
    Whittington HJ; Hall AR; McLaughlin CP; Hausenloy DJ; Yellon DM; Mocanu MM
    Cardiovasc Drugs Ther; 2013 Feb; 27(1):5-16. PubMed ID: 23192487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin improves cardiac function in mice with heart failure after myocardial infarction by regulating mitochondrial energy metabolism.
    Sun D; Yang F
    Biochem Biophys Res Commun; 2017 Apr; 486(2):329-335. PubMed ID: 28302481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening.
    Bhamra GS; Hausenloy DJ; Davidson SM; Carr RD; Paiva M; Wynne AM; Mocanu MM; Yellon DM
    Basic Res Cardiol; 2008 May; 103(3):274-84. PubMed ID: 18080084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart.
    Yan W; Zhang H; Liu P; Wang H; Liu J; Gao C; Liu Y; Lian K; Yang L; Sun L; Guo Y; Zhang L; Dong L; Lau WB; Gao E; Gao F; Xiong L; Wang H; Qu Y; Tao L
    Basic Res Cardiol; 2013 May; 108(3):329. PubMed ID: 23460046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The heart is better protected against myocardial infarction in the fed state compared to the fasted state.
    Liepinsh E; Makrecka M; Kuka J; Makarova E; Vilskersts R; Cirule H; Sevostjanovs E; Grinberga S; Pugovics O; Dambrova M
    Metabolism; 2014 Jan; 63(1):127-36. PubMed ID: 24140100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic rats by preserving mitochondrial function: role of AMPK-PGC-1α-SIRT3 signaling.
    Yu L; Gong B; Duan W; Fan C; Zhang J; Li Z; Xue X; Xu Y; Meng D; Li B; Zhang M; Bin Zhang ; Jin Z; Yu S; Yang Y; Wang H
    Sci Rep; 2017 Jan; 7():41337. PubMed ID: 28120943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective effect of L-glutamate in obese type 2 diabetic Zucker fatty rats.
    Povlsen JA; Løfgren B; Rasmussen LE; Nielsen JM; Nørregaard R; Kristiansen SB; Bøtker HE; Nielsen TT
    Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):892-8. PubMed ID: 19298538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration.
    Solskov L; Løfgren B; Kristiansen SB; Jessen N; Pold R; Nielsen TT; Bøtker HE; Schmitz O; Lund S
    Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):82-7. PubMed ID: 18484962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glimepiride treatment facilitates ischemic preconditioning in the diabetic heart.
    Hausenloy DJ; Wynne AM; Mocanu MM; Yellon DM
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):263-9. PubMed ID: 23263382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling.
    Calvert JW; Gundewar S; Jha S; Greer JJ; Bestermann WH; Tian R; Lefer DJ
    Diabetes; 2008 Mar; 57(3):696-705. PubMed ID: 18083782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotection by acetylcholine: a novel mechanism via mitochondrial biogenesis and function involving the PGC-1α pathway.
    Sun L; Zhao M; Yu XJ; Wang H; He X; Liu JK; Zang WJ
    J Cell Physiol; 2013 Jun; 228(6):1238-48. PubMed ID: 23139024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure.
    Gundewar S; Calvert JW; Jha S; Toedt-Pingel I; Ji SY; Nunez D; Ramachandran A; Anaya-Cisneros M; Tian R; Lefer DJ
    Circ Res; 2009 Feb; 104(3):403-11. PubMed ID: 19096023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protective effect of ischemia and diazoxide preconditioning on postischemic reperfused myocardium and possible mechanism thereof].
    Han JS; Yan DM; Wang ZW; Zhu HY
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):555-8. PubMed ID: 18649773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
    Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
    Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute metformin treatment provides cardioprotection via improved mitochondrial function in cardiac ischemia / reperfusion injury.
    Palee S; Higgins L; Leech T; Chattipakorn SC; Chattipakorn N
    Biomed Pharmacother; 2020 Oct; 130():110604. PubMed ID: 32777704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin Increases Cardiac Rupture After Myocardial Infarction via the AMPK-MTOR/PGC-1α Signaling Pathway in Rats with Acute Myocardial Infarction.
    Hua J; Liu Z; Liu Z; An D; Lai W; Zhan Q; Zeng Q; Ren H; Xu D
    Med Sci Monit; 2018 Oct; 24():6989-7000. PubMed ID: 30275441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
    Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of metformin and liraglutide cardioprotective effect in rats with impaired glucose tolerance.
    Simanenkova A; Minasian S; Karonova T; Vlasov T; Timkina N; Shpilevaya O; Khalzova A; Shimshilashvili A; Timofeeva V; Samsonov D; Borshchev Y; Galagudza M
    Sci Rep; 2021 Mar; 11(1):6700. PubMed ID: 33758265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury.
    Khandoudi N; Delerive P; Berrebi-Bertrand I; Buckingham RE; Staels B; Bril A
    Diabetes; 2002 May; 51(5):1507-14. PubMed ID: 11978649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of omega-3 fatty acids and metformin combination on diabetic cardiomyopathy in rats through autophagic pathway.
    Eraky SM; Ramadan NM
    J Nutr Biochem; 2021 Nov; 97():108798. PubMed ID: 34102283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.